FUS and liposarcoma: Moreover, the N-terminal domain of FUS, which was identified as the transcriptional activator in FUS-CHOP and FUS-ERG fusion proteins in liposarcoma and myeloid sarcoma respectively (54,55), was recently shown to be sufficient to contact the SWI/SNF chromatin remodelling complex (52).